92 filings
Page 2 of 5
8-K
tiw59
3 Apr 23
Biomea Fusion Announces Proposed Public Offering of Common Stock
4:06pm
424B5
7guxpa4b4jx 5r
30 Mar 23
Prospectus supplement for primary offering
4:06pm
424B5
w9wd8gw ffjlotk2
29 Mar 23
Prospectus supplement for primary offering
6:56am
8-K
gie1kjpot
28 Mar 23
Regulation FD Disclosure
5:06pm
8-K
lzg 2n5gv134c
28 Mar 23
Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:11pm
8-K
2jz1nezg1wis
12 Jan 23
Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones
4:06pm
S-8
yly4yjtj94e1tz
4 Jan 23
Registration of securities for employees
4:06pm
8-K
n3aw2s w8yxyeo
16 Dec 22
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent Menin Inhibitor BMF-219 in Type 2 Diabetes
4:06pm
8-K
mgr 75cmhi3
13 Dec 22
Other Events
4:14pm
8-K
ct6rlkquefc9
25 Nov 22
Entry into a Material Definitive Agreement
1:59pm
424B5
t0d3ynrv8c si5
25 Nov 22
Prospectus supplement for primary offering
1:51pm
8-K
4ewgcbgcih5iufrunrn
7 Nov 22
Biomea Fusion Reports Third Quarter 2022 Financial Results and Business Highlights
4:08pm
8-K
kmjjiq28xrjtp126o
1 Nov 22
Other Events
4:06pm
EFFECT
0jzp1xzsz23 fzpiz3k
25 Oct 22
Notice of effectiveness
12:15am
CORRESP
v9aw m6i0
20 Oct 22
Correspondence with SEC
12:00am
UPLOAD
ps47falljtwnxzf1 3w6
19 Oct 22
Letter from SEC
12:00am
8-K
yz7dw5 d8wi
18 Oct 22
Other Events
4:06pm